Hrt Financial LP Aclaris Therapeutics, Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.01 - $1.36 $81,815 - $110,166	81,005 New	81,005 $89,000
Q4 2022 Feb 10, 2023	BUY	$14.33 - $18.37 $652,516 - $836,477	45,535 New	45,535 $717,000
Q2 2021 Aug 16, 2021	SELL	$17.08 - $29.6 $2.6 Million - $4.5 Million	-152,119 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $891,417 - $4.22 Million	152,119 New	152,119 $3.83 Million
Q1 2020 May 15, 2020	SELL	$0.75 - $2.18 $36,992 - $107,524	-49,323 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.02 - $1.97 $50,309 - $97,166	49,323 New	49,323 $93,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.